Author:
Shibata Shoyo,Uemura Ryotaro,Suzuki Takeshi
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference11 articles.
1. IMS Health Inc. IMS Health Market Prognosis, June 2013. Danbury, CT: IMS Health Inc.
2. Japan Pharmaceutical Manufacturers Association. Pharmaceutical Administration and Regulations in Japan, 2014. Tokyo, Japan: Japan Pharmaceutical Manufacturers Association.
3. DiMasi JA, Hansen RW, Grabowski HG, et al. Cost of innovation in the pharmaceutical industry. J Health Econ. 1991;10:107–142.
4. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22:151–185.
5. Getz KA, Wenger J, Campo RA, Seguine ES, Kaitin K. Assessing the impact of protocol design changes on clinical trial performance. Am J Ther. 2008;15:450–457.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献